B7-H7 has been proven to serve as a standalone predictor of prognosis in patients with multiple solid tumors, including lung cancer, gastric cancer, pancreatic cancer, liver cancer, and oral cancer (6–11). This evidence concerns the gene HHLA2 and familial pancreatic carcinoma.